Nath Bio-Genes India Ltd posts Rs. 1.43 crore consolidated PAT in Q4 FY2022-23
The Board of Directors of Nath Bio-Genes India Limited, at its meeting held today have approved the financial results of the company for the period ended March 31, 2023 - Q4FY23 and FY2023.
Source: equitybulls.com